Interferon-gamma gene expression during acute graft-versus-host disease: Relationship to MHC induction and tissue injury

Journal of Pathology

Volumn 189, Issue 1, 1999, Pages 99-104

  Parfrey, Nollaig A ^a,b   El Sheikh, Amr ^b   Monckton, Elizabeth A ^b   Cockfield, Sandra M ^b   Halloran, Philip F ^b   Linetsky, Elina ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Gene expression; Graft versus host disease; Interferon ; Major histocompatibility complex; Tissue injury

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; IN SITU HYBRIDIZATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN INDUCTION; TISSUE INJURY;

ANIMALS; BLOTTING, NORTHERN; BRAIN; GENE EXPRESSION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IN SITU HYBRIDIZATION; INTERFERON TYPE II; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MYOCARDIUM; SPLEEN; TONGUE;

EID: 0032867745     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199909)189:1<99::AID-PATH404>3.0.CO;2-F     Document Type: Article

References (24)

1. Parfrey NA, Ste-Croix H, Prud'homme GJ. Evidence that nonlymphoid tissue injury in acute graft-versus-host disease is limited to epithelial cells aberrantly expressing MHC antigens. Transplantation 1989; 48: 655-660.
2. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russell PS. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med 1985; 162: 1645-1664.
3. Shaw J, Meerovitch K, Elliot JF, Bleackley RC, Paetkau V. Induction, suppression and superinduction of lymphokine mRNA in T lymphocytes. Mol Immunol 1987; 24: 409.
4. Cockfield SM, Ramassar V, Halloran PF. Regulation of IFN-γ and tumor necrosis factor-α expression in vivo. Effects of cycloheximide and cyclosporine in normal and lipopolysaccharide-treated mice. J Immunol 1993; 150: 342-352.
5. Halloran PF, Jepthah-Ochola J, Urmson J, Farkas S. Systemic immunologic stimuli increase class I and II antigen expression in mouse kidney. J Immunol 1985; 135: 1053-1060.
6. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidmium isothiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
7. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
8. Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ, Kirschner MW. Number and evolutionary conservation of α-and β-tubulin and cytoplasmic β-and α-actin genes using specific cloned cDNA probes. Cell 1980; 20: 95-105.
9. Mueller C, Gershenfeld HK, Lobe CG, Okada CY, Bleackley RC, Weissman IL. A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the mel-14-defined lymph node homing receptor. J Exp Med 1988; 167: 1124-1136.
10. Hickey WF, Kimura H. Graft-versus-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci USA 1987; 84: 2082-2086.
11. Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985; 6: 131-136.
12. Goes N, Sims T, Urmson G, Vincent D, Ramassar V, Halloran PF. Disturbed MHC regulation in the IFN-γ knockout mouse. Evidence for three states of MHC expression with distinct roles for IFN-γ. J Immunol 1995; 155: 4559-1566.
13. Herberman R, Ortaldo JR, Bonnard GD. Augmentation by interferon of human natural and antibody-dependent cell mediated cytotoxicity. Nature 1979; 277: 221.
14. Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin-1. Diabetes 1988; 37: 133-136.
15. Cleveland MG, Annable CR, Klimpel GR. In vivo and in vitro production of IFN-β and IFN-γ during graft-versus-host disease. J Immunol 1988; 141: 3349-3356.
16. Niederwieser D, Harold M, Woloszcuk W, et al. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 1990; 50: 620-625.
17. Tanaka J, Imamura M, Kasai M, et al. Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 1993; 85: 558-565.
18. Rowbottom AW, Norton J, Riches PG, Hobbs JR, Powles RL, Sloane JP. Cytokine gene expression in skin and lymphoid organs in graft-versus-host disease. J Clin Pathol 1993; 46: 341-345.
19. Kichian K, Nestel FP, Kim D, Pouka P, Lapp WS. IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma. J Immunol 1996; 157: 2851-2856.
20. Mowat AM. Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus-host disease reaction. Immunology 1989; 68: 18-23.
21. Klimpel GR, Annable CR, Cleveland MG, Jerrells TR, Patterson JC. Immunosuppression and lymphoid hypoplasia associated with chronic graft-versus-host disease is dependent upon IFN-γ production. J Immunol 1990; 144: 84-93.
22. Brok HPM, Heidt PJ, van der Meide PH, Zurcher C, Vossen JM. Interferon-γ prevents graft-versus-host disease after allogeneic bone marrow translantation in mice. J Immunol 1993; 151: 6451-6459.
23. Wall DA, Sheehan KCF. The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency. Transplantation 1994; 57: 273-279.
24. Cockfield SM, Ramassar V, Noujaim J, van der Meide P, Halloran PF. Regulation of IFN-γ expression In vivo. IFN-γ regulates expression of its mRNA in normal and lipopolysaccharide-stimulated mice. J Immunol 1993; 150: 717-725.